Chemistry:ONO-2020

From HandWiki

ONO-2020 is an epigenetic modulator, immunomodulator, and possible cognitive enhancer which is under development for the treatment of agitation including due to Alzheimer's disease.[1][2][3][4] It is taken orally.[1] The drug's exact mechanism of action or biological target does not yet appear to have been disclosed.[1][2][3][4] ONO-2020 is under development by Ono Pharmaceutical.[1][2][3][4] As of May 2025, it is in phase 2 clinical trials for treatment of agitation and Alzheimer's disease.[1][2][3][4] The chemical structure of ONO-2020 does not yet appear to have been disclosed.[1]

See also

  • List of investigational agitation drugs

References